Is NVAX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,353 people get NVAX articles and Market Currents by email alert.

Get email alerts on NVAX »

HEADLINES:

Will Influenza A H7N9 Generate Opportunities For Pharma?
Jean-Christophe Larsimont • Tue, May 21 • 5 Comments
6 Superstars For Your Biotech Portfolio: John McCamant
Life Sciences Report • Fri, May 10 • 1 Comment
Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing

GlobeNewswire (May 10, 2013)
Novavax's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 7
Novavax Reports First-Quarter 2013 Financial Results

GlobeNewswire (May 7, 2013)
China's H7N9 Bird Flu And Novavax
Trent MacDonald • Fri, May 3 • 17 Comments
Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price
Kapitall • Wed, May 1 • 2 Comments
Novavax to Report First-Quarter 2013 Financial Results on May 7, 2013

GlobeNewswire (Apr 26, 2013)
Novavax to Present at 12th Annual Needham Healthcare Conference

GlobeNewswire (Apr 25, 2013)
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Healthcare Specialist • Tue, Apr 16 • 18 Comments
Novavax to Review Recent Findings from Vaccine Programs at World Vaccine Congress and Expo in Washington, DC

GlobeNewswire (Apr 15, 2013)
Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs

GlobeNewswire (Apr 10, 2013)
Novavax: My $1.30 Biotech Lottery Ticket - Up 80% And Heading Higher
Bret Jensen • Mon, Apr 8 • 10 Comments
Flu Stocks For Investors To Consider
Stock Investor • Mon, Apr 8 • 6 Comments
Biotechs Ramping Up On China's Avian Flu Outbreak
David Zanoni • Mon, Apr 8 • 12 Comments
Novavax's CEO Discusses RSV Vaccine Candidate Phase II Top Line Results (Transcript)
Wed, Apr 3
Does This Hot Biotech Still Have Legs Or Is It Time To Take Profits?
EnhydrisPECorp • Wed, Apr 3 • 5 Comments
Novavax Reports Positive Top-Line Results From Phase II Clinical Trial of RSV Vaccine Candidate in Women of Childbearing Age

GlobeNewswire (Apr 2, 2013)
2 Speculative $2 Biotech Stocks Insiders Are Buying
Bret Jensen • Tue, Mar 19 • 13 Comments
Novavax Reports Progress on RSV Vaccine at the XV International Symposium on Respiratory Viral Infections

GlobeNewswire (Mar 18, 2013)

To learn more about Seeking Alpha Pro, click here.

China's H7N9 Bird Flu And Novavax
Trent MacDonald • Fri, May 3 • 17 Comments
Novavax: My $1.30 Biotech Lottery Ticket - Up 80% And Heading Higher
Bret Jensen • Mon, Apr 8 • 10 Comments
Does This Hot Biotech Still Have Legs Or Is It Time To Take Profits?
EnhydrisPECorp • Wed, Apr 3 • 5 Comments
'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
Michael Webb • Wed, Nov 14, 2012 • 61 Comments
3 Reasons To Buy Novavax
Markus Aarnio • Mon, Jun 25, 2012 • 12 Comments
Is The Novavax 'New Paradigm' Worth A Second Look?
M. E. Garza • Fri, May 4, 2012 • 8 Comments
Insider Buy At Novavax Spurs Speculation
M. E. Garza • Mon, Apr 16, 2012 • 3 Comments
8 Reasons To Buy This $1.30 Lottery Ticket
Bret Jensen • Sun, Mar 11, 2012 • 39 Comments
Novavax Has Over 400% Upside Potential
Jeremy Richards • Tue, Apr 19, 2011 • 14 Comments
Novavax Lands BARDA Contract and Licensing Deal
M. E. Garza • Tue, Mar 1, 2011 • 3 Comments
Encouraging Results from Novavax
Zacks Investment Research • Tue, Mar 30, 2010 • 1 Comment
Novavax Soars After Influenza Vaccine Deal
M. E. Garza • Fri, Jun 5, 2009 • 2 Comments
Novavax Advances Avian Flu Vaccine Despite Government Snub
H.S. Ayoub • Wed, Jan 24, 2007
Novavax Should Jump On Avian Flu Results
Microcap Speculator • Tue, Jan 23, 2007
Smallcap Novavax Has Turned a Corner
Microcap Speculator • Tue, Dec 5, 2006
Novavax Stuck in Downtrend
Microcap Speculator • Mon, Jul 24, 2006

Will Influenza A H7N9 Generate Opportunities For Pharma?
Jean-Christophe Larsimont • Tue, May 21 • 5 Comments
6 Superstars For Your Biotech Portfolio: John McCamant
Life Sciences Report • Fri, May 10 • 1 Comment
Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price
Kapitall • Wed, May 1 • 2 Comments
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Healthcare Specialist • Tue, Apr 16 • 18 Comments
Flu Stocks For Investors To Consider
Stock Investor • Mon, Apr 8 • 6 Comments
Biotechs Ramping Up On China's Avian Flu Outbreak
David Zanoni • Mon, Apr 8 • 12 Comments
2 Speculative $2 Biotech Stocks Insiders Are Buying
Bret Jensen • Tue, Mar 19 • 13 Comments
George Zavoico: Biotech Stocks That Deserve A Closer Look
Life Sciences Report • Fri, Mar 8 • 1 Comment
Speculative Flu Vaccine Stocks To Consider: Novavax, iBio, BioCryst, And Inovio
BuySellShort • Fri, Jan 11 • 14 Comments
Investment Opportunities Surface With 3 Vaccine Players
Cris Frangold • Tue, Nov 6, 2012 • 4 Comments
The Figure-4 Dead Fall Trap And 4-Biotechnology Recommendations For October
Michael Webb • Thu, Oct 18, 2012 • 24 Comments
3 Vaccine Companies With Near Term Catalysts
Markus Aarnio • Tue, Sep 4, 2012 • 7 Comments
Analyst Greg Wade Bets On Extraordinary Science And Clinical Data
Life Sciences Report • Thu, Aug 30, 2012
Micro Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Jul 11, 2012 • 9 Comments
2 Biotech Lottery Tickets, Each For Less Than $2
Bret Jensen • Tue, Jul 10, 2012 • 15 Comments
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
GuruFundPicks • Sat, May 19, 2012 • 2 Comments
Analyzing Wednesday's Noteworthy Insider Trades
GuruFundPicks • Thu, Apr 12, 2012
Micro Cap Biotech Stocks Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Mar 28, 2012 • 10 Comments
7 Best-Performing, Heavily Traded Biotechs Of The Year Under $10
Kinetic Investments • Mon, Jan 30, 2012 • 7 Comments
Past Bouncers And Others Biotech Plays Ready To Move
MarketScanners • Thu, Jan 26, 2012 • 2 Comments

Novavax's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 7
Novavax's CEO Discusses RSV Vaccine Candidate Phase II Top Line Results (Transcript)
Wed, Apr 3
Novavax Management Discusses Q4 2012 Results - Earnings Call Transcript
Fri, Mar 1 • 1 Comment
Novavax's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Fri, Nov 2, 2012
Novavax Management Discusses Q2 2012 Results - Earnings Call Transcript
Fri, Aug 3, 2012
Novavax, Inc. Q3 2008 Earnings Call Transcript
Mon, Nov 10, 2008
Novavax, Inc. Q2 2008 Earnings Call Transcript
Tue, Sep 2, 2008

Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing

GlobeNewswire (May 10, 2013)
Novavax Reports First-Quarter 2013 Financial Results

GlobeNewswire (May 7, 2013)
Novavax to Report First-Quarter 2013 Financial Results on May 7, 2013

GlobeNewswire (Apr 26, 2013)
Novavax to Present at 12th Annual Needham Healthcare Conference

GlobeNewswire (Apr 25, 2013)
Novavax to Review Recent Findings from Vaccine Programs at World Vaccine Congress and Expo in Washington, DC

GlobeNewswire (Apr 15, 2013)
Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs

GlobeNewswire (Apr 10, 2013)
Novavax Reports Positive Top-Line Results From Phase II Clinical Trial of RSV Vaccine Candidate in Women of Childbearing Age

GlobeNewswire (Apr 2, 2013)
Novavax Reports Progress on RSV Vaccine at the XV International Symposium on Respiratory Viral Infections

GlobeNewswire (Mar 18, 2013)
Novavax to Present at the 25th Annual ROTH Conference

GlobeNewswire (Mar 13, 2013)
Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013

GlobeNewswire (Mar 8, 2013)
Novavax Reports Fourth Quarter and Year-End 2012 Financial Results

GlobeNewswire (Mar 1, 2013)
Novavax to Report 2012 Fourth-Quarter and Year-End Financial Results on March 1, 2013

GlobeNewswire (Feb 22, 2013)
NOVAVAX to Present at the 15th Annual Bio CEO & Investor Conference

GlobeNewswire (Feb 7, 2013)
BARDA Continues Novavax' Influenza Vaccine Programs Following In-Process Review

GlobeNewswire (Jan 24, 2013)
Novavax' Phase I RSV Vaccine Data Published in Vaccine

GlobeNewswire (Dec 6, 2012)
Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate

GlobeNewswire (Dec 3, 2012)
Novavax to Present at the 24th Annual Piper Jaffray Healthcare Conference

GlobeNewswire (Nov 20, 2012)
Novavax to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

GlobeNewswire (Nov 12, 2012)
Novavax Reports Third-Quarter 2012 Financial Results

GlobeNewswire (Nov 2, 2012)
Novavax to Report Third Quarter 2012 Financial Results on November 2, 2012

GlobeNewswire (Oct 26, 2012)

NVAX vs. ETF Alternatives

Company Description

Novavax, Inc., a Delaware corporation (“Novavax” or the “Company”), was incorporated in 1987, and is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. These... More

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 5:47 PM After-hours top gainers, as of 5:30 p.m.: ENDP +3.6%. NVAX +2.8%. GRFS +2.7%. REE +2.6%. IMRS +2.4%.
AftTer-hours top losers: ET -4.0%. APTS -3.7%. SYNC -3.6%. SSRI -2.7%. VG -2.5%. Comment! [On the Move]
Tuesday, May 7, 8:05 AM Novavax (NVAX): Q1 EPS of -$0.07 misses by $0.01. Revenue of $3.8M misses by $1.74M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, May 7, 12:05 AM Notable earnings before Tuesday’s open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC 2 Comments [Earnings]
Monday, May 6, 5:30 PM Notable earnings before Tuesday's open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC Comment! [Earnings]
Monday, April 15, 9:15 AM Premarket gainers: S +16%. SVA +13%. BCRX +10%. LIFE +8%. NFP +7%. MGT +7%. TMO +6%. THRX +5%. NVAX +5%.
Losers: AAU -15%. MTL -10%. AUQ -11%. HMY -9%. NGD -8%. CEF -8%. SLW -8%. SAND -9%. KGC -7%. AUY -7%. GOLD -7%. MUX -7%. DSCO -7%. IAG -6%. SVM -6%. GG -6%. PAAS -6%. EGO -6%. AU -5%. CDE -5%. Comment! [On the Move]
Monday, April 15, 8:39 AM Biotechs rise in early trading as the death toll from the new avian flu strain jumps to 13. Sinovac (SVA) is preparing immunizations and can manufacture 30-40M doses annually, according to Bloomberg. Meanwhile, investors continue to bet BioCryst's (BCRX) peramavir could have a role to play. Premarket moves: SVA +9.6%, BCRX +7.4%, NVAX +5%. Comment! [On the Move, Healthcare]
Friday, April 5, 11:09 AM BioCryst Pharmaceuticals (BCRX +17.4%) pops on news that six deaths in China have been linked to a new strain of avian flu. BCRX is developing peramivir, which has been shown in preclinical studies to help treat highly virulent strains of influenza - including the bird flu strain known as the H5N1 virus. Other drug stocks moving higher on the news: Pure Bioscience (PURE +15.6%), Hemispherx BioPharma (HEB +13.3%), Sinovac Biotech (SVA +7.8%), and Novavax (NVAX +1.1%). Comment! [Healthcare, On the Move]
Friday, April 5, 9:10 AM Premarket gainers: XIDE +31%. NIHD +10%. NVAX +5%.
Losers: RIGL -36%. FFIV -18%. RDWR -18%. JNPR -7%. CBMX -5%. Comment! [On the Move]
Wednesday, April 3, 9:10 AM Premarket gainers: CALL +14%. CONN +10%. ZNGA +10%. ASTX +10%. UNXL +9%. AWRE +9%. OMPI +9%. NVAX +9%. ALXA +8%. MHR +7%. NFX +6%.
Losers: MSPD -19%. GPN -7%. 3 Comments [On the Move]
Tuesday, April 2, 6:08 PM Novavax (NVAX) says its respiratory syncytial virus vaccine met objectives in a Phase II clinical trial. The company says the drug was well-tolerated and there "were no clinically important differences in systemic adverse events between placebo and active vaccine recipients." Shares +7% AH. Comment! [Healthcare]
Tuesday, April 2, 5:36 PM After-hours top gainers, as of 5:15 p.m.: CALL +17%. NVAX +6%. ZOLT +6%. NFX +5%. ZNGA +5%.
After-hours top losers: KOS -10%. GPN -6%. VOD -4%. SEP -4%. OXM -3%. Comment! [On the Move]
Monday, March 18, 8:49 AM Novavax's (NVAX) vaccine for respiratory syncytial virus (RSV), which causes respiratory tract infections, produced encouraging results in preclinical studies, inducing anti-RSV antibodies in vitro and cutting infectious RSV in a cotton rat challenge model. In clinical and preclinical studies, antibodies were generated at concentrations "significantly above that found to be protective in both humans and cottons rats." The vaccine is in Phase I and Phase II trials. (PR) 1 Comment [Healthcare]
Friday, March 1, 8:03 AM Novavax (NVAX): Q4 EPS of -$0.06 misses by $0.01. Revenue of $4.56M misses by $2.48M. (PR) 1 Comment [Earnings, Breaking News, Healthcare]
Friday, March 1, 12:05 AM Notable earnings before Friday’s open: AMRC, BBY, EVEP, FWLT, HPT, MGA, NVAX, POM, XLS Comment! [Earnings]
Thursday, February 28, 5:30 PM Notable earnings before Friday’s open: AMRC, BBY, EVEP, FWLT, HPT, MGA, NVAX, POM, XLS Comment! [Earnings]
Friday, November 2, 2012, 8:05 AM Novavax (NVAX): Q3 EPS of -$0.05 in-line. Revenue of $5.8M (+16% Y/Y) misses by $2M. (PR) Comment! [Earnings, Healthcare]

Bullnanke
$NVAX.... what a shame.
May 8, 9:49 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kapitall
Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Price $BDSI $NVAX $QCOR http://seekingalpha.com/a/trpf
May 1, 6:15 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Bullnanke
$NVAX.. same old story.. the manipulation continues, I wonder when they will announce an offering, as they artificially keep the price down!
Apr 26, 3:29 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Bullnanke
$NVAX...big expo later today.. should be exciting developments.. big inst. and hedge fund ownership... keep close eye on it..
Apr 16, 9:21 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$NVAX Novavax is no doubt redirecting some of its efforts to help contain the bird flu epidemic in China http://reut.rs/XVgjPT
Apr 5, 3:19 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Bullnanke
$NVAX... $5 by July.. $20 will be a bargain for big pharma.. All you have to do is LOOK at the institutional ownership.. :)
Apr 1, 5:00 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$NVAX CEO Stanley Erck reports plans to market a combination RSV/Influenza "RESPIRATORY VACCINE" to infants 6 mos to 6 years old. Up .03 AH
Mar 21, 12:36 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Bullnanke
$NVAX... great company.. but with strong market (and more so in biotechs)..this stock should be 3-4$$...More dilutions to come??
Mar 15, 4:43 PM
Reply (33)

• !Report Abuse
View all 33 replies
Bullnanke: Don't give 'em away Mike.. $20 bux and we meet in Vegas for that bottle. :) Good Luck to us all..
Apr 5, 8:51 AM
• !Report Abuse
Bullnanke: In the meantime.. Let's see if the MACHINE keeps leaning on it again (in the face of great trials??)..WHO is selling ???and WHY?
Apr 5, 9:26 AM
• !Report Abuse
Add a reply...

140 characters

Bullnanke
$NVAX,,I don't understand why "THEY" never let this stock breathe... They keep doing offerings and lean all over the stock..ALWAYS!!!.
Mar 15, 4:43 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Webb
$NVAX James F Young, PhD Board of Directors Novavax purchases 100k shares @$2.03 Wonder why? http://on.mktw.net/X8WGPx
Mar 14, 1:52 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

freefdawatchlist
http://stks.co/gDLl Premarket gainer $GIVN (12%), $NVAX(7%), $AEGR(6%)
10/18/12
Reply (1)

• !Report Abuse
View all 1 replies
Michael Webb: Hey Bull! It's been so good I've been thinking about taking some profits. You?
Apr 10, 8:00 PM
• !Report Abuse
Add a reply...

140 characters

Bullnanke
$NVAX... great company.. but with strong market (and more so in biotechs)..this stock should be 3-4$$...More dilutions to come??
Mar 15, 4:43 PM
Reply (33)

• !Report Abuse
View all 33 replies
Bullnanke: Don't give 'em away Mike.. $20 bux and we meet in Vegas for that bottle. :) Good Luck to us all..
Apr 5, 8:51 AM
• !Report Abuse
Bullnanke: In the meantime.. Let's see if the MACHINE keeps leaning on it again (in the face of great trials??)..WHO is selling ???and WHY?
Apr 5, 9:26 AM
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/28/12
Reply (2)

• !Report Abuse
View all 2 replies
iadops40: http://bit.ly/RntWCr
8/28/12
• !Report Abuse
DAG1996: thanks for sharing that.
8/28/12
• !Report Abuse
Add a reply...

140 characters

iadops40
Huge all-star biotech conference (Rodman & Renshaw) in New York Sept. 9-11 CLSN GALE GERN IBIO INO KERX NVAX NBS ONTY VVUS
8/27/12
Reply (1)

• !Report Abuse
View all 1 replies
iadops40: http://bit.ly/RntWCr
8/27/12
• !Report Abuse
Add a reply...

140 characters

Jim Van Meerten
NVAX - 96% Barchart technical buy signal - 19 new highs and up 69.29% in the alst month - Relative Strength Index 89.03%
7/19/12
Reply (2)

• !Report Abuse
View all 2 replies
eltimbomofo: watching that one myself
7/19/12
• !Report Abuse
Jim Van Meerten: Not followed by many
7/19/12
• !Report Abuse
Add a reply...

140 characters

iadops40
PPHM CLSN NVAX bringing back the life for my bio spec picks
7/12/12
Reply (4)

• !Report Abuse
View all 4 replies
DAG1996: thanks. my ATRS average is $2... not sure i'd still buy at this level, but might add if it can stay steadily in the $5-6 range a while.
7/12/12
• !Report Abuse
DAG1996: i just saw someone mentioned an 8K but my eyes and brain are too tired to make sense of an 8K right now so i'll have to read in the morn
7/12/12
• !Report Abuse
Add a reply...

140 characters

DAG1996
NVAX off to the races... no idea why yet but still happy with it
1/23/12
Reply (3)

• !Report Abuse
View all 3 replies
DAG1996: ahh, ok thanks.
1/23/12
• !Report Abuse
DAG1996: apparently an outbreak of swine flu in Mexico & 12 Americans H1N1 too
1/23/12
• !Report Abuse
Add a reply...

140 characters

NVAX Novavax, Inc.

NVAX

Novavax, Inc.